Yield response of improved upland pasture to the control of leatherjackets under increasing rates of nitrogen

In each year from 1984-5 to 1987-8 the effect of leatherjackets on yield of improved upland pasture was assessed at Redesdale Experimental Husbandry Farm in Northumberland. Chlor-pyrifos at 0.72 kg ha⁻¹ was applied in November or December to half the plots; these and the untreated plots received one of four fertilizer rates (0, 40, 80, 120 kg N ha⁻¹). All rates increased yield by a mean of about 24 kg DM kg N⁻¹.
There was a significant correlation (Y (t DM ha⁻¹) = 0-21 + 0-00168 ×, r = 0-99 ( P = 0.001)) between yield response to chlorpyrifos and leatherjacket numbers m⁻² in November/ December. Treatment thresholds for leatherjacket numbers are given.     

Equine neural angiostrongylosis

Verminous encephalomyelitis due to Angiostrongylus cantonensis larvae was diagnosed in 2 foals at necropsy. The principal clinical feature was tetraparesis, although history and neurological examination revealed progressive and multifocal neurological disease. At presentation, a tentative diagnosis of parasitic larval migration involving the central nervous system (CNS), presumably due to Strongylus vulgaris, was proposed. Dissection of the spinal cord in one case resulted in recovery of intact larvae of both sexes of A. cantonensis. In both foals, histopathology of the brain and spinal cord revealed nematode sections which were consistent with A. cantonensis larvae.     

Pharmacokinetics of gentamicin after intravenous and subcutaneous injection in obese cats

Six adult domestic shorthair obese cats were given 3-mg/kg gentamicin sulfate by rapid i.v. and by s.c. injection in a cross-over design. The plasma concentration-time data were analyzed using statistical moment theory with no assumption of a specific compartmental model. Means +/- SD for the half-life, which was calculated from the terminal slope of the log concentration-time curve, were 1.37 +/- 0.24 and 1.24 +/- 0.22 h following i.v. and s.c. injection, respectively. The apparent volume of distribution at steady state was 118.55 +/- 19.83 ml/kg, and total body clearance was 1.07 +/- 0.25 ml/kg/min. Bioavailability was 83.58 +/- 14.83% after s.c. administration. The calculated s.c. dose in obese cats to produce an average steady-state concentration of 4 micrograms/ml is 2.5 mg/kg every 8 h compared to 3 mg/kg in normal-weight cats.     

Metrizamide myelography in sixty-eight dogs

The results of 68 metrizamide myelograms in the dog are recorded, involving both cisternal and lumbar punctures. The technical considerations are described together with interpretation of the normal myelogram and the diagnostic signs. Failure to obtain a good contrast column occurred in 14 dogs, and post myelographic signs were observed in eight.     

Pharmacokinetics of oral rufinamide in dogs

Wright, H. M., Chen, A. V., Martinez, S. E., Davies, N. M. Pharmacokinetics of oral rufinamide in dogs. J. vet. Pharmacol. Therap.  35 , 529–533. The objective of this study was to determine the pharmacokinetic properties and short‐term adverse effect profile of single‐dose oral rufinamide in healthy dogs. Six healthy adult dogs were included in the study. The pharmacokinetics of rufinamide were calculated following administration of a single mean oral dose of 20.0 mg/kg (range 18.6–20.8 mg/kg). Plasma rufinamide concentrations were determined using high‐performance liquid chromatography, and pharmacokinetic data were analyzed using commercial software. No adverse effects were observed. The mean terminal half‐life was 9.86 ± 4.77 h. The mean maximum plasma concentration was 19.6 ± 5.8 μg/mL, and the mean time to maximum plasma concentration was 9.33 ± 4.68 h. Mean clearance was 1.45 ± 0.70 L/h. The area under the curve (to infinity) was 411 ± 176 μg·h/mL. Results of this study suggest that rufinamide given orally at 20 mg/kg every 12 h in healthy dogs should result in a plasma concentration and half‐life sufficient to achieve the therapeutic level extrapolated from humans without short‐term adverse effects. Further investigation into the efficacy and long‐term safety of rufinamide in the treatment of canine epilepsy is warranted.     

A study of the radiographic anatomy of the foramen magnum in dogs

The shape and size of the foramen magnum were investigated in a number of breeds. It was found that dorsal extension occurred in toy breeds, both with and without neurological symptoms. An increase in the size of the foramen magnum was not necessarily associated with a pathological process.